Phase II study of bendamustine in patients with relapsed or cisplatin-refractory germ cell cancer.
about
Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study GroupRecent advances in the treatment of testicular cancer.Recent advances in management of patients with platinum-refractory testicular germ cell tumors.Investigation of bendamustine HCL in a phase 2 study in women with resistant ovarian cancer.Absence of c-KIT and members of the epidermal growth factor receptor family in refractory germ cell cancer.
P2860
Phase II study of bendamustine in patients with relapsed or cisplatin-refractory germ cell cancer.
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Phase II study of bendamustine ...... n-refractory germ cell cancer.
@ast
Phase II study of bendamustine ...... n-refractory germ cell cancer.
@en
Phase II study of bendamustine ...... n-refractory germ cell cancer.
@nl
type
label
Phase II study of bendamustine ...... n-refractory germ cell cancer.
@ast
Phase II study of bendamustine ...... n-refractory germ cell cancer.
@en
Phase II study of bendamustine ...... n-refractory germ cell cancer.
@nl
prefLabel
Phase II study of bendamustine ...... n-refractory germ cell cancer.
@ast
Phase II study of bendamustine ...... n-refractory germ cell cancer.
@en
Phase II study of bendamustine ...... n-refractory germ cell cancer.
@nl
P2093
P1433
P1476
Phase II study of bendamustine ...... n-refractory germ cell cancer.
@en
P2093
Bokemeyer C
Kollmannsberger C
Schleucher N
P304
P356
10.1097/00001813-200008000-00003
P577
2000-08-01T00:00:00Z